Toyama Chemical Applies For Approval Of Pediatric Antimicrobial Agent
This article was originally published in PharmAsia News
Executive Summary
Toyama Chemical applied for approval of Ozex powder for pediatric use. A newquinolone antimicrobial agent, the drug is indicated to treat pediatric pneumonia and otitis media. Ozex pediatric is based on the Ozex tablet that was developed and launched by the company in 1990. Toyama Chemical changed the tablet into powder for easier adjustment in dosage. Upon approval, Ozex pediatric will be the first newquinolone antimicrobial agent to treat pediatric pneumonia in Japan. (Click here for more - Japanese language